CurrentBlue Cross Blue Shield - MassachusettsPolicy 660

660_Cognitive_Rehabilitation_Policy

Defines the medical policy for outpatient cognitive rehabilitation services, summarizing evidence across indications (TBI, dementia, stroke, MS, epilepsy, ASD, encephalopathy, cancer, COVID-19/post-COVID) and describing policy history and clinical input; this is part 2 of 2 and contains evidence, references, COVID-19 considerations, and policy history.

Policy Summary

PayerBlue Cross Blue Shield - Massachusetts

Policy660_Cognitive_Rehabilitation_Policy

Policy CodePolicy 660

Change TypeLiterature reviewcoding clarificationsstate-mandated COVID-19 coverage

Effective DateJan 1, 2021

Next Review DateN/A

Key ActionDocument cognitive impairment due to traumatic brain injury and rationale for cognitive rehabilitation as medical necessity based on clinical evaluation and professional input.

SourceLink

POLICY UPDATE CHANGES

Policy updated with literature review through June 4, 2025; references added.

Policy updated with literature review through February 1, 2024; references added. Policy statements unchanged.

Clarified coding information (multiple historical entries: 10/2021, 1/2020, 1/2018, 10/2017, etc.).

Policy updated to include coverage for cognitive rehabilitation for cognitive impairment resulting from COVID-19 in the outpatient setting in accordance with state mandate Chapter 260 of the Acts of 2020; Effective 1/1/2021.

Minor editorial refinements to policy statements; intent unchanged (5/2023).

Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

Coverage summary & scope

This policy defines coverage for outpatient cognitive rehabilitation services across multiple indications including TBI, dementia, stroke, MS, epilepsy, autism spectrum disorder, post-encephalopathy, cancer-related cognitive deficits, and COVID-19/post-COVID. It summarizes the evidence base, policy history, and clinical input and is labeled as part 2 of 2 containing evidence, references, COVID-19 considerations, and policy history.

Coverage takeaway: For most indications the evidence is insufficient to demonstrate improvement in net health outcome; however, TBI may be considered medically necessary based on clinical input, and dementia shows mixed RCT results with some functional benefit needing replication.

Evidence-based coverage conclusions by indication

Evidence-based coverage summary by indication

Coverage conclusions are based on the evidence summarized for each condition:

ALL of the following

Traumatic brain injury (TBI): Clinical input and some trials support use; cognitive rehabilitation may be considered medically necessary for TBI per clinical input.
Dementia (mild to moderate): Trials and systematic reviews show mixed results; some RCTs (e.g., goal-oriented programs) show benefits on certain functional outcomes but evidence is insufficient for net health outcome improvement.
Stroke: Systematic reviews and RCTs show no benefit or clinically important effects; evidence insufficient to determine net health outcome improvement.
Multiple sclerosis (MS): RCTs and systematic reviews show no consistent significant effects; heterogeneity and lack of high-quality trials limit conclusions; evidence insufficient for durable clinically significant improvements.
Epilepsy, ASD, post-encephalopathy, cancer-related cognitive deficits: Epilepsy, autism spectrum disorder (ASD), post-encephalopathy, cancer-related cognitive deficits: Few studies, methodologic limitations, short follow-up; systematic reviews generally not supportive; evidence insufficient to determine net health outcome improvement.
COVID-19 / Post-COVID cognitive impairment: Policy was updated to include coverage for outpatient cognitive rehabilitation for cognitive impairment resulting from COVID-19 per Massachusetts state mandate (Chapter 260 of the Acts of 2020); evidence summarized includes systematic reviews/observational studies and emerging trials, but overall evidence is mixed.

Indications lacking sufficient evidence

Indications identified with insufficient evidence or limited support from systematic reviews/RCTs include: stroke (systematic reviews and RCTs show no benefit or clinically important effects), multiple sclerosis (MS) (heterogeneous RCTs, no consistent durable clinically significant effects), epilepsy, autism spectrum disorder (ASD), post-encephalopathy, and cancer-related cognitive deficits (few studies, methodological limitations, short follow-up; systematic reviews generally not supportive).

Coding information

Coding information (clarified historically)mixed

No codes listed

Actions for providers (prior auth, documentation, billing)

Documentation Required

Medical necessity for TBI

Document cognitive impairment due to traumatic brain injury and rationale for cognitive rehabilitation as medical necessity based on clinical evaluation and professional input.

Prior Authorization

State-mandated coverage for COVID-19 related cognitive impairment

Coverage for outpatient cognitive rehabilitation for cognitive impairment resulting from COVID-19 was added effective 2021-01-01 in accordance with Massachusetts Chapter 260 of the Acts of 2020; providers should follow applicable plan prior authorization and billing processes.

Effective date: 2021-01-01
Reminder: follow applicable plan prior authorization and billing processes

Operational implications: cognitive rehabilitation for TBI may be provided as medically necessary per clinical input and should be documented with clinical evaluation and rationale. Per state mandate (Chapter 260 of the Acts of 2020) outpatient coverage for cognitive rehabilitation for COVID-19-related cognitive impairment was added effective 1/1/2021. Providers should document clinical diagnosis, functional impact, and expectation of improvement and follow applicable prior authorization and billing processes for outpatient services.

Background & evidence overview

Background: The policy summarizes systematic reviews, randomized trials, and observational studies across multiple neurologic and medical conditions to assess efficacy of cognitive rehabilitation. Clinical input supporting use in traumatic brain injury was obtained in 2010 and reaffirmed in 2015. In response to a Massachusetts state mandate (Chapter 260 of the Acts of 2020) outpatient coverage for cognitive rehabilitation related to COVID-19 was added effective 1/1/2021.

Evidence conclusion: Overall evidence is insufficient to determine improved net health outcomes for most indications; the notable exception is that TBI may be considered medically necessary based on clinical input.

Relevant Medicare LCDs

LCD Number & Name	Effective Date / Type
L34427 - Outpatient Occupational Therapy - L34427	Effective: (not specified in policy) / Type: LCD
L33631 - Outpatient Physical and Occupational Therapy Services - L33631	Effective: (not specified in policy) / Type: LCD

Policy revision timeline

2025-06-04literature_reviewLatest

Policy updated with literature review through June 4, 2025; references added.

2024-02-01literature_review

Policy updated with literature review through February 1, 2024; references added. Policy statements unchanged.

2023-05editorial